Trial intelligence / Profile preview

Memantine Add-on in Bipolar I Non-responders

NCT02630888Phase 2Unknown

Sponsor
Universidade de São Paulo
Start
Aug 2014
Primary completion
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of memantine in bipolar I disorder, sponsored by Universidade de São Paulo. Status: unknown.

02

Drugs

memantine
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on NCT02630888.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02630888.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call